lifestyle.capitolhilltimes.com

Author: Equillium, Inc.

Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event

April 20, 2026
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists

April 8, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 2, 2026
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights

March 25, 2026
Equillium to Participate in the 38th Annual Roth Conference

March 18, 2026
Equillium Announces $35 Million Financing with RA Capital Management

March 13, 2026
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference

February 25, 2026
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 2, 2026